Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients Results from the OVCAD study

E. I. Braicu, C. Fotopoulou, T. Van Gorp, R. Richter, R. Chekerov, C. Hall, H. Butz, D. Cacsire Castillo-Tong, S. Mahner, R. Zeillinger, N. Concin, I. Vergote, J. Sehouli

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)245-251
JournalGynecologic Oncology
Volume128
Issue number2
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Ovarian cancer
  • HE4
  • CA125
  • Surgical outcome

Cite this